If you want a Stock Review on SHPG, AERI, HRTX, or UTHR then come over to http://dailystocktracker.com/register …
The year-to-date return of United Therapeutics Corporation (NASDAQ:UTHR)’s stock is almost 34%, and it trades at a …
stock is biggest percentage decliner in S&P 1500 healthcare sector and on track for worst one-day drop since Feb ** Co said late on Thurs that an independent monitoring committee said pulmonary arterial hypertension study involving …
United Therapeutics Corporation (Nasdaq: UTHR) announced that its Board has approved and declared a stock split. The stock split will be effected in the form of a stock dividend, in which one share of United Therapeutics common stock will …
Mr. Paul A. Mahon, J.D. is Executive Vice President, General Counsel, Corporate Secretary of the Company. He has served as General Counsel and Corporate Secretary of United Therapeutics since its inception in 1996. In June 2001, …
The matter pertains to the above-mentioned patent, which is held by United Therapeutics Corp. (UTHR). The patent claims a product ... Following the update, SteadyMed stock was trading 60% higher during pre-market hours, and hit a 52 …
United Therapeutics Corp. UTHR, -0.06% shares surged 8.7% premarket on Friday after a news report suggested that major pharmaceutical companies were weighing a bid for it. The Evening Standard report said that Gilead Sciences Inc. …
Shares are up after Jim Cramer spoke favorable of the stock on his “Mad Money” TV show. United Therapeutics Corporation (NASDAQ: UTHR) is down roughly 6% premarket to $58.90, relative to a 52-week range of $46.14-$70.74. …
United Therapeutics Corp. (NASDAQ: UTHR), a biotechnology company ... That expedites the regulatory approval process. (For more stock ideas, see The Online Investor: www.theonlineinvestor.com) - There is no dividend. Two numbers stand …
If you want a Stock Review on SHPG, AERI, HRTX, or UTHR then come over to http://dailystocktracker.com/register/ …